Nothing Special   »   [go: up one dir, main page]

Nam et al., 2020 - Google Patents

Helicity modulation improves the selectivity of antimicrobial peptoids

Nam et al., 2020

View PDF
Document ID
8325710149306491090
Author
Nam H
Choi J
Kumar S
Nielsen J
Kyeong M
Wang S
Kang D
Lee Y
Lee J
Yoon M
Hong S
Lund R
Jenssen H
Shin S
Seo J
Publication year
Publication venue
ACS infectious diseases

External Links

Snippet

The modulation of conformational flexibility in antimicrobial peptides (AMPs) has been investigated as a strategy to improve their efficacy against bacterial pathogens while reducing their toxicity. Here, we synthesized a library of helicity-modulated antimicrobial …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Similar Documents

Publication Publication Date Title
Nam et al. Helicity modulation improves the selectivity of antimicrobial peptoids
Edwards et al. Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides
Lyu et al. Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism
Wang et al. Combating drug-resistant fungi with novel imperfectly amphipathic palindromic peptides
Chen et al. High selective performance of designed antibacterial and anticancer peptide amphiphiles
Rathinakumar et al. Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes
Song et al. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues
Avrahami et al. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to d, l-amino acid-containing antimicrobial peptides: a plausible mode of action
Agbale et al. Antimicrobial and antibiofilm activities of helical antimicrobial peptide sequences incorporating metal-binding motifs
Ma et al. Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units
Malgieri et al. Structural basis of a temporin 1b analogue antimicrobial activity against Gram negative bacteria determined by CD and NMR techniques in cellular environment
Thennarasu et al. Limiting an antimicrobial peptide to the lipid− water interface enhances its bacterial membrane selectivity: a case study of MSI-367
Batoni et al. Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties
Lohan et al. Recent approaches in design of peptidomimetics for antimicrobial drug discovery research
Zhong et al. New antimicrobial peptides with repeating unit against multidrug-resistant bacteria
Li et al. Novel β-hairpin antimicrobial peptides containing the β-turn sequence of-RRRF-having high cell selectivity and low incidence of drug resistance
Arnusch et al. Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents
Monteiro et al. A 17-mer membrane-active MSI-78 derivative with improved selectivity toward bacterial cells
Azmi et al. Characterization of antimicrobial, cytotoxic, and antiendotoxin properties of short peptides with different hydrophobic amino acids at “a” and “d” positions of a heptad repeat sequence
Sowinska et al. Bioinspired amphiphilic peptide dendrimers as specific and effective compounds against drug resistant clinical isolates of E. coli
Baeriswyl et al. X-ray crystal structures of short antimicrobial peptides as Pseudomonas aeruginosa lectin B complexes
Ouyang et al. Improving the antimicrobial performance of amphiphilic cationic antimicrobial peptides using glutamic acid full-scan and positive charge compensation strategies
Wynn et al. Branched peptides: Acridine and boronic acid derivatives as antimicrobial agents
Lorin et al. Revisiting peptide amphiphilicity for membrane pore formation
Hu et al. Lysine stapling screening provides stable and low toxic cationic antimicrobial peptides combating multidrug-resistant bacteria in vitro and in vivo